What's in Université de Lubumbashi's pipeline?

Université de Lubumbashi has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Université de Lubumbashi's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universit-de-lubumbashi.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Université de Lubumbashi — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Université de Lubumbashi pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Pyrethroids	Pyrethroids	marketed			Other
synergistic combination of insecticides	synergistic combination of insecticides	marketed	Insecticide combination		Parasitology/Vector Control

Therapeutic area mix

Other · 1
Parasitology/Vector Control · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Université de Lubumbashi:

Cite this brief

Drug Landscape (2026). Université de Lubumbashi — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universit-de-lubumbashi. Accessed 2026-05-16.